CORINE JOHNSON: Open Payments
NPI 1871963728 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 17 payments from 8 companies in 2025. Trend: 2023 $2,917 · 2024 $4,017 · 2025 $462
Food & beverage: $445Travel & lodging: $16
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $137 |
| ABBVIE INC. | 4 | $113 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $78 |
| Janssen Biotech, Inc. | 3 | $68 |
| QOL Medical, LLC | 1 | $20 |
| Madrigal Pharmaceuticals | 1 | $16 |
| Ardelyx, Inc. | 1 | $16 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
Products named: BOTOX, XIFAXAN, TREMFYA, RINVOQ, ENTYVIO, Sucraid, REZDIFFRA, IBSRELA.
Industry payments across TX — which companies pay providers there.
